Bloomberg Talks

Merck CEO Rob Davis Talks Winrevair Approval

Mar 28, 2024
Guest
Rob Davis
Merck CEO Rob Davis discusses the approval of Winrevair for high blood pressure. Topics include FDA approval, strategic portfolio diversification for diseases like fatty liver, and analysis of healthcare costs and drug pricing disparities between the US, Europe, and the UK.
Ask episode
Chapters
Transcript
Episode notes
1
Merck's FDA Approval and Strategic Portfolio Diversification
00:00 • 5min
2
Analysis of Healthcare Costs and Drug Pricing in the US vs Europe
05:21 • 2min